Search results
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle...
Benzinga via Yahoo Finance· 3 hours agoA young patient died due to cardiac arrest after receiving Pfizer Inc’s (NYSE:PFE) experimental gene...
Pfizer Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 11 hours agoPfizer Inc (NYSE:PFE) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors...
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 7 hours agoPfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn...
Pfizer agrees to settle more than 10,000 Zantac cancer lawsuits
Chicago Tribune· 5 hours agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 1 day agoA young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy...
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
Reuters· 8 hours agoPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 hours agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
Is Pfizer Stock Fully Valued At $28?
Forbes· 2 days agoPfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the street estimates.
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 4 days agoReaders hoping to buy Pfizer Inc. (NYSE:PFE) for its dividend will need to make their move shortly,...
Pfizer reports fatality in Phase II DMD gene therapy study
Clinical Trials Arena via Yahoo Finance· 12 hours agoPfizer has reported the death of a patient in the Phase II DAYLIGHT study of experimental gene...